168 332

Cited 0 times in

Clinical features of acute viral hepatitis B in Korea: a multi-center study

DC Field Value Language
dc.contributor.authorChoi, HJ-
dc.contributor.authorKo, SY-
dc.contributor.authorChoe, WH-
dc.contributor.authorSeo, YS-
dc.contributor.authorKim, JH-
dc.contributor.authorByun, KS-
dc.contributor.authorKim, YS-
dc.contributor.authorKim, SU-
dc.contributor.authorBaik, SK-
dc.contributor.authorCheong, JY-
dc.contributor.authorKim, TY-
dc.contributor.authorKwon, OS-
dc.contributor.authorLee, CH-
dc.contributor.authorKwon, SY-
dc.date.accessioned2014-03-06T04:38:34Z-
dc.date.available2014-03-06T04:38:34Z-
dc.date.issued2011-
dc.identifier.issn1738-222X-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/9609-
dc.description.abstractBackground/Aims: The incidence of Hepatitis B has significantly declined since the introduction of an HBV vaccination program. The aim of this study was to investigate recent clinical features of acute viral hepatitis B (AVH-B) in Korea.



Methods: A total of 2241 patients with acute viral hepatitis were enrolled and their data were collected from nine medical-centers between January 2006 and December 2009.



Results: One hundred nineteen (5.3%) of the 2241 were diagnosed as AVH-B. Among 78 patients with AVH-B whose data were analyzed, 50 were male, and the mean age was 38.6 years. In an initial test, mean AST, ALT and total-bilirubin levels were 1296.2 IU/L, 2109.6 IU/L and 9.3 mg/dl, respectively. Positivity frequencies for HBeAg and anti-HBe were 55.1% and 67.9%, respectively, and the mean HBV DNA level was 5.2 log10 copies/ml. The mean length of hospitalization was 11.6 days. During follow-up, AST, ALT and total bilirubin levels were normalized or near-normalized in all patients without serious complications. Sixty-three of 66 (95.4%) patients showed HBsAg loss and 37 (56.1%) patients showed HBsAg seroconversion. Only 3 patients (4.5%) showed persistent hepatitis B viremia. There was no case of death or liver transplantation. Nine patients (11.3%) had received anti-viral agents and their clinical outcomes were not significantly different from those of patients treated without antiviral agents.



Conclusions: The prevalence of AVH-B among acute hepatitis patients is relatively low in Korea. AVH-B infection can be cured without complications in almost all patients, regardless of antiviral treatment.
-
dc.language.isoen-
dc.titleClinical features of acute viral hepatitis B in Korea: a multi-center study-
dc.typeArticle-
dc.identifier.urlhttp://www.e-cmh.org/journal/view.php?number=4081-
dc.subject.keywordAcute hepatitis B-
dc.subject.keywordPrevalence-
dc.subject.keywordPrognosis-
dc.contributor.affiliatedAuthor정, 재연-
dc.type.localJournal Papers-
dc.citation.titleThe Korean journal of hepatology-
dc.citation.volume17-
dc.citation.number4-
dc.citation.date2011-
dc.citation.startPage307-
dc.citation.endPage312-
dc.identifier.bibliographicCitationThe Korean journal of hepatology, 17(4):307-312, 2011-
dc.identifier.eissn2093-8047-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Gastroenterology
Files in This Item:
The Korean journal of hepatology_17(4)_307-312.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse